Cargando…

Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt‐1 (Soluble fms‐Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio

BACKGROUND: There is little knowledge about the significance of extremely high values (>655) for the ratio of sFlt‐1 (soluble fms‐like tyrosine kinase 1) to PlGF (placental growth factor). We aim to describe the time‐to‐delivery interval and maternal and perinatal outcomes when such values are de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villalaín, Cecilia, Herraiz, Ignacio, Valle, Leonor, Mendoza, Manel, Delgado, Juan Luis, Vázquez‐Fernández, María, Martínez‐Uriarte, Juan, Melchor, Íñigo, Caamiña, Sara, Fernández‐Oliva, Antoni, Villar, Olga Patricia, Galindo, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428600/ https://www.ncbi.nlm.nih.gov/pubmed/32248765 http://dx.doi.org/10.1161/JAHA.119.015548

Ejemplares similares

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Hussein, Sama, et al.
Publicado: (2022)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy
por: Neuman, Rugina I., et al.
Publicado: (2021)

A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome
por: Stepan, H., et al.
Publicado: (2016)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Nuzzo, Anna Maria, et al.
Publicado: (2021)

The sFlt-1/PlGF Ratio in Pregnant Patients Affected by COVID-19
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2023)

Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
por: Sá, Catherine Primo Nogueira de, et al.
Publicado: (2020)

Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
por: Stepan, H, et al.
Publicado: (2015)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK
por: Vatish, M., et al.
Publicado: (2016)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Schlembach, Dietmar, et al.
Publicado: (2018)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016)

sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19
por: Soldavini, Chiara Maria, et al.
Publicado: (2022)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
por: Kozłowski, Szymon, et al.
Publicado: (2021)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
por: Middendorf, Lisa, et al.
Publicado: (2022)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
por: Powers, Robert W., et al.
Publicado: (2010)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Pant, Vivek, et al.
Publicado: (2019)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
por: Witwicki, Jacek, et al.
Publicado: (2021)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia
por: Lee, Jaekyoung, et al.
Publicado: (2021)

Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management
por: Nobrega, Guilherme M., et al.
Publicado: (2023)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)

The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 Infection
por: Di Martino, Daniela Denis, et al.
Publicado: (2022)

sFlt‐1/PlGF for prediction of early‐onset pre‐eclampsia: STEPS (Study of Early Pre‐eclampsia in Spain)
por: Perales, A., et al.
Publicado: (2017)

Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
por: Sovio, Ulla, et al.
Publicado: (2021)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
por: Mayer-Pickel, Karoline, et al.
Publicado: (2019)

Long-term observational study of renal outcome after preeclampsia: Role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin
por: Thitivichienlert, Thanaphan, et al.
Publicado: (2022)

Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
por: Graupner, Oliver, et al.
Publicado: (2021)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia
por: Karpova, Nataliia Sergeevna, et al.
Publicado: (2023)

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
por: Bian, Xuming, et al.
Publicado: (2019)

Longitudinal circulating placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in Asian women: a prospective cohort study
por: Ng, Qiu Ju, et al.
Publicado: (2019)

Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?
por: Muttukrishna, Shanthi, et al.
Publicado: (2011)

PlGF, immune system and hypertension
por: Carnevale, Daniela, et al.
Publicado: (2015)

sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective
por: Hodel, Markus, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qvjs1klbiapaj1jlk00l4n9372